RESEARCH
TRIANGLE PARK, N.C., Aug. 5, 2024
/PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer
of therapies for bladder and bowel dysfunction, announced that
Dr. Rabchevsky has joined Dignify's Scientific Advisory Board
(SAB). Dr. Rabchevsky is currently Professor of Physiology and
inaugural faculty member of the Spinal Cord & Brain Injury
Research Center at the University of
Kentucky in Lexington, KY. Sasha also served as President of
the Board of Directors of Unite to Fight Paralysis and has received
numerous awards and honors for his research in the field of spinal
injury pathophysiology. Dr. Rabchevsky's research has focused on
molecular and subcellular repair of the spinal cord following
injury, yet his unique expertise extends to improving the overall
well-being of individuals after experiencing neurological
trauma.
"I am extremely excited to join Dignify's SAB. Having lived with
a spinal injury for almost 40 years, and experience daily chronic
bladder and bowel dysfunction, I am grateful that there is a
company that is dedicated to finding new pharmaceutical approaches
for bladder and bowel treatments for people with spinal cord
injury, multiple sclerosis, and other neuropathies," Sasha
explained. "I look forward to providing Dignify with direction for
their clinical trial designs and product development that includes
guidance from those living with spinal injury/disease."
"We are very proud to have Sasha join Dignify's SAB. We look
forward to his guidance and expertise as we focus on advancing our
therapies for the treatment of bladder and bowel disorders,
especially as they apply to people with neurological deficits such
as spinal injury," said Dr. Karl
Thor, Chief Scientific Officer of Dignify. "I am confident
that Dr. Rabchevsky will be a significant contributor to our
development of novel treatments that will allow people with spinal
injury, neurological disease, diabetes, and the elderly to regain
'on-demand' control of bladder and bowel voiding to eliminate many
of the associated social, professional, financial, and physical
burdens of bladder and bowel dysfunction."
About Dignify Therapeutics
Founded by a team of serial entrepreneurs who are
internationally recognized scientists and clinicians, Dignify's
mission is to provide safe, effective, practical and convenient,
"on-demand" pharmaceutical agents to treat bladder and bowel
voiding dysfunctions. The company has been funded by RA Capital
Management, Eshelman Ventures, the North Carolina Biotechnology
Center, NIDDK, NINDS, NICHD, NIA, US Defense Department, and the
One NC Small Business Program. Dignify is located at the First
Flight Venture Center in Research
Triangle Park, North Carolina.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dignify-therapeutics-welcomes-leading-spinal-injury-expert-alexander-sasha-rabchevsky-phd-to-its-scientific-advisory-board-302208907.html
SOURCE Dignify Therapeutics